Clinical Trial Update: Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical pharmacological study of the AL-43546 ophthalmic product in subjects with dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• AL-43546

Snippet

Sponsor: Alcon Research | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED